We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the Department for Business and Trade (DBT).
This recognition highlights Congenica’s commitment to delivering innovative genomic data analysis and interpretation solutions that drive Precision Medicine at scale. As the exclusive Clinical Decision Support Partner for the NHS Genomic Medicine Service, we continuously help reduce the burden on the UK healthcare system by providing state-of-the-art technology, market-leading automation, and machine learning within our CE-marked platform.
Alistair Johnson, Chief Commercial Officer at Congenica, said: “We are delighted to have been showcased within the Genomics Spotlight 2024 report! With our commitment to global quality standards, our fully automated, integrated, and scalable end-to-end solution is driving Precision Medicine and enables healthcare providers to deliver the highest quality care to their patients in a timely manner. We look forward to continuing our mission to transform healthcare through the power of genomic data.”
To view the report – click here.
